GAMMADELTA THERAPEUTICS

gammadelta-therapeutics-logo

GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.

#SimilarOrganizations #People #Financial #Website #More

GAMMADELTA THERAPEUTICS

Industry:
Biotechnology Health Care Health Diagnostics Therapeutics

Founded:
2016-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.gammadeltatx.com

Total Employee:
51+

Status:
Closed

Contact:
+44 (0207) 6911122

Email Addresses:
[email protected]

Total Funding:
100 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Person Schema Gravatar Profiles Amazon Route 53 DMARC AWS Global Accelerator


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

carbylan-therapeutics-logo

Carbylan Therapeutics

Carbylan Therapeutics was founded in 2004

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

ieso-logo

ieso

Transforming mental healthcare by unlocking the power of clinical data

imutex-logo

Imutex

Imutex, a startup with a Phase IIa-ready universal flu vaccine.

mavalon-therapeutics-logo

Mavalon Therapeutics

Mavalon is developing drugs to stop the progression of Parkinson's disease.

vivan-therapeutics-logo

VIVAN Therapeutics

VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.

orbus-therapeutics-logo

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

stemsight-logo

StemSight

StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

stromal-therapeutics-logo

Stromal Therapeutics

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

treos-bio-logo

Treos Bio

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.


Current Advisors List

adrian-hayday_image

Adrian Hayday Board Member @ GammaDelta Therapeutics
Board_member

Current Employees Featured

sandra-van-wetering_image

Sandra Van Wetering
Sandra Van Wetering VP Process Science and Manufacturing @ GammaDelta Therapeutics
VP Process Science and Manufacturing
2020-08-01

adrian-hayday_image

Adrian Hayday
Adrian Hayday Co-Founder @ GammaDelta Therapeutics
Co-Founder

Founder


adrian-hayday_image

Adrian Hayday

Acquisitions List

Date Company Article Price
2018-05-31 Lymphact Lymphact acquired by GammaDelta Therapeutics N/A

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Venture Round - GammaDelta Therapeutics

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Venture Round - GammaDelta Therapeutics

cancer-research-technology_image

Cancer Research Horizons

Cancer Research Horizons investment in Seed Round - GammaDelta Therapeutics

kings-college-london_image

King's College London

King's College London investment in Seed Round - GammaDelta Therapeutics

the-francis-crick-institute_image

The Francis Crick Institute

The Francis Crick Institute investment in Seed Round - GammaDelta Therapeutics

abingworth-management_image

Abingworth

Abingworth investment in Seed Round - GammaDelta Therapeutics

Official Site Inspections

http://www.gammadeltatx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.33 K

  • Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
  • IP address: 76.223.3.151
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "GammaDelta Therapeutics"

GammaDelta Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +44 (0207) 6911122 GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved …See details»

GammaDelta Therapeutics - LinkedIn

GammaDelta Therapeutics | 6,449 followers on LinkedIn. GammaDelta Therapeutics is a UK headquartered biotechnology company founded upon world-class academic research …See details»

GammaDelta Therapeutics - 2025 Company Profile - Tracxn

May 28, 2025 GammaDelta Therapeutics is developing immunotherapeutics for cancer-based gamma delta (γδ) T cells. The company has received seed funding Abingworth and also has …See details»

Gammadelta Therapeutics Ltd. - Drug pipelines, Patents, Clinical …

May 8, 2025 Explore Gammadelta Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 23 news, and 11 literature, Disease Domain:Neoplasms, …See details»

GammaDelta Therapeutics initiates first-in-human phase 1 trial of ...

London, UK, 15 Sept 2021: GammaDelta Therapeutics Ltd. (GDT), a biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for …See details»

Overview, News & Similar companies - ZoomInfo.com

Who is GammaDelta Therapeutics. GammaDelta Therapeutics is working to develop improved immunotherapies for cancer and other serious diseases. The company's research and …See details»

GammaDelta Therapeutics - PitchBook

GammaDelta Therapeutics General Information Description. Developer of immunotherapies designed to treat cancer and auto-immune diseases. The company's immunotherapies use t …See details»

GammaDelta Therapeutics - Craft

GammaDelta Therapeutics is a company committed to transforming the treatment of patients living with hematological and solid cancers. It develops cancer therapy based on the body’s …See details»

GammaDelta Therapeutics Company Profile | Management and

Www.gammadeltatx.com . Contact Information. Headquarters. 195 Wood White City Poland Ln, London, Greater London, W12 7FQ, United Kingdom +44 2080516710. GammaDelta …See details»

GammaDelta Therapeutics - VentureRadar

"GammaDelta Therapeutics aims to harness the unique properties of ?d T cells to improve patient outcomes and survival rates among patients with haematological malignancies and solid …See details»

GammaDelta Therapeutics Company Overview, Contact Details

Oct 11, 2018 | gammadeltatx.com GammaDelta Therapeutics Ltd hired Michael Koslowski on Jun 10th '18. GammaDelta Therapeutics Ltd, an emerging biotech company developing novel …See details»

GammaDelta Therapeutics Overview | SignalHire Company Profile

Organization Website: gammadeltatx.com : Phone Number: 44-0207-6911122: GammaDelta Therapeutics industries Biotech: Headquarters Location: London, GB London, GB : …See details»

Takeda to Acquire GammaDelta Therapeutics to Accelerate …

Oct 27, 2021 Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic γδT Cell Therapies Addressing Solid TumorsSee details»

GammaDelta - Ownership and Business Overview - Mergr

Www.gammadeltatx.com. Profile Investors (1) Analytics GammaDelta is a clinically-staged biotechnology company pioneering the discovery and development of allogeneic gamma delta …See details»

GammaDelta Therapeutics - Company Profile & Staff Directory

About GammaDelta Therapeutics. GammaDelta Therapeutics is a UK headquartered biotechnology company founded upon world-class academic research conducted by Professor …See details»

GammaDelta Therapeutics Receives FDA Clearance of IND …

May 20, 2021 First-in-human clinical study for Acute Myeloid Leukaemia expected to begin later in 2021; FDA also granted orphan drug designation to GDX012 for the treatment of Acute …See details»

GammaDelta Therapeutics | EU-Startups

GammaDelta Therapeutics aims to harness the unique properties of γδ T cells to improve patient outcomes and survival rates among patients with haematological malignancies and solid …See details»

Takeda and GammaDelta Therapeutics Announce Collaboration to …

May 9, 2017 Contact GammaDelta Therapeutics Ltd: Raj Mehta Director of Intellectual Property, Alliance Management and Business Development Paolo Paoletti, MD CEO T: +44 (0) 207 691 …See details»

Takeda buys GammaDelta to boost cancer cell therapy credentials

5 days ago Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in 'off-the-shelf' cell therapies for solid tumours and …See details»

Takeda Acquires GammaDelta Therapeutics - pharmtech.com

Nov 2, 2021 Takeda announced that it had exercised its option to acquire GammaDelta Therapeutics, a biotechnology company focused on using gamma delta (γx) T cells (T …See details»

linkstock.net © 2022. All rights reserved